Inner Mongolia Furui Medical Soars 12.91% to Hit Intraday High of CNY 45.25

Inner Mongolia Furui Medical Science Co., Ltd. has experienced a significant surge in its stock price, gaining 12.91% on July 1, 2026. The stock reached an intraday high of CNY 45.25, reflecting strong performance compared to the broader market, as the China Shanghai Composite index only rose by 0.44% on the same day. Over the past week, Inner Mongolia Furui Medical Science has shown an 8.53% increase, further highlighting its recent upward momentum. However, the stock's performance over the past month has been less favorable, with a decline of 3.11%. In contrast, the company has demonstrated impressive growth over the past year, with a return of 35.83%, significantly outpacing the China Shanghai Composite's 18.93% gain. Despite these positive indicators, the company faces challenges in long-term growth, with net sales and operating profit growing at annual rates of 15.97% and 24.64%, respectively, over the last five years. The stock's price-to-earnings ratio stands at 34.00, indicating a relatively high valuation in the pharmaceuticals and biotechnology sector.